Brief: Painreform Ltd Says Company's Supplier Of API Has Received A Deficiency Notice From FDA Related To Its Drug Master File

PRF Technologies

07/06/2023 22:25

June 7 (Reuters) - PainReform Ltd  PRFX.O :
    * PAINREFORM PROVIDES REGULATORY UPDATE ON SECOND PART OF
ITS
PHASE 3 CLINICAL TRIAL OF PRF-110 IN PATIENTS UNDERGOING
BUNIONECTOMY SURGERY
    * PAINREFORM LTD- COMPANY'S SUPPLIER OF API (ACTIVE
PHARMACEUTICAL
INGREDIENT) HAS RECEIVED A DEFICIENCY NOTICE FROM FDA RELATED TO
ITS DRUG MASTER FILE
    * PAINREFORM- PART 2 OF PHASE 3 TRIAL EXPECTED TO COMMENCE
ONCE
REQUIRED INFORMATION PROVIDED BY SUPPLIER TO FDA, DEFICIENCY
NOTICE HAS BEEN RESOLVED

Source text for Eikon:  ID:nGNX480Cvf 
Further company coverage:  PRFX.O 

 ((Reuters.Briefs@thomsonreuters.com;;))